Thomas A. Bologna
Vorsitzender bei CDx Diagnostics, Inc.
Profil
Is an experienced Chairman, President and Chief Executive Officer in leading public, venture and private equity backed diagnostic, pharmaceutical, device and clinical laboratory testing healthcare companies including turnarounds and start-ups, many of which he sold and/or took public.
Mr. Bologna was Chairman of the Board and Chief Executive Officer of Response Genetics, Inc., a clinical laboratory company, President and Chief Executive Officer of Orchid Cellmark, Inc., a leading DNA testing services company with operations in the United States and Europe, President and Chief Executive Officer of Quorex Pharmaceuticals, Chairman of the Board, President and Chief Executive Officer of Ostex International, Inc., a company that developed and commercialized products for the therapeutic management of osteoporosis and Chairman of the Board, President and Chief Executive Officer of Gen-Probe, Incorporated, a highly successful molecular diagnostics company.
Mr. Bologna also held senior level positions of highly profitable healthcare divisions and subsidiaries of Fortune 500 companies including President of the Becton Dickinson Diagnostic Instrument Systems Division.
He was also a founder and member of the Sponsoring Committee of the venture capital firm, Mission Ventures.
Mr. Bologna received his B.S.
from the New York University School of Engineering and Science and his M.B.A.
from the New York University Graduate School of Business Administration.
Aktive Positionen von Thomas A. Bologna
| Unternehmen | Position | Beginn |
|---|---|---|
CDx Diagnostics, Inc.
 CDx Diagnostics, Inc. Medical SpecialtiesHealth Technology CDx Diagnostics, Inc. develops and delivers instruments for detection and prevention of cancers. It is a specialized pathology lab that utilizes patented CDx Technology to analyze a disaggregated tissue specimen of the entire thickness of the suspect epithelium. The firm involves in detection and prevention of cancers of the esophagus, oral cavity, pharynx, and larynx. CDx Diagnostics provides clinicians with unique tools to enhance their detection of precancerous change through complete epithelial sampling combined with computer-assisted morphological and molecular laboratory analysis. The company was founded by Mark Rutenberg and Drore Eisen in 1997 and is headquarters in Suffern, NY. | Vorsitzender | - |
Galen Management LLC
 Galen Management LLC Investment ManagersFinance Galen Management LLC (Galen Management) Is a private equity firm founded in 1990 by John Wilkerson and William Grant. The firm is headquartered in Stamford, Connecticut. | Private Equity Investor | - |
CDx Medical Holdings, Inc.
 CDx Medical Holdings, Inc. Medical/Nursing ServicesHealth Services CDx Medical Holdings, Inc. engages in the provision of healthcare services. The company is headquartered in Suffern, NY. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Thomas A. Bologna
| Unternehmen | Position | Ende |
|---|---|---|
| QUOTIENT LIMITED | Direktor/Vorstandsmitglied | 29.10.2020 |
| STANDARD DIVERSIFIED INC | Vorsitzender | 24.12.2013 |
| RESPONSE GENETICS, INC | Vorstandsvorsitzender | 09.10.2015 |
Cylex, Inc.
 Cylex, Inc. Medical SpecialtiesHealth Technology Cylex is a privately held global life science company that is in the development and manufacture of in vitrodiagnostic products. ImmuKnow is the in vitro diagnostic utilized to detect cell-mediated immunity (CMI) in an immunosuppressed population and is increasingly being adopted at organ transplant centers throughout the United States and abroad. The Company's patented technology provides a platform allowing clinical researchers to simply and reproducibly measure CMI for the development of new diagnostics, biomarkers and companion assays. The company is based in Columbia, MD and was founded in 1992 | Direktor/Vorstandsmitglied | 18.11.2013 |
Aperio Technologies, Inc.
 Aperio Technologies, Inc. Medical SpecialtiesHealth Technology Aperio Technologies, Inc. provided digital pathology systems and services. Its scanners created a digital image of an entire microscope slide at giga-pixel resolution in minutes, with inherently superior image quality. The company was founded in 1999 and was headquartered in Vista, CA. | Direktor/Vorstandsmitglied | - |
Ausbildung von Thomas A. Bologna
| New York University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BECTON, DICKINSON AND COMPANY | Health Technology |
| RESPONSE GENETICS, INC | Health Technology |
| Private Unternehmen | 15 |
|---|---|
Warner-Lambert Co.
 Warner-Lambert Co. Pharmaceuticals: MajorHealth Technology Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ. | Health Technology |
| Ostex International, Inc. | Health Technology |
Standard Diversified, Inc.
 Standard Diversified, Inc. TobaccoConsumer Non-Durables Standard Diversified, Inc. is a holding company, which owns and operates subsidiaries in a variety of industries, including other tobacco products, insurance, and outdoor advertising. It operates through the following segments: Smokeless Products, Smoking Products, and NewGen Products. The Smokeless Product segment manufactures and markets moist snuff and contracts for and markets chewing tobacco products. The Smoking Products segment imports and markets cigarette papers, tubes, and related products; imports and markets finished cigars, MYO cigar tobaccos, and cigar wraps; and processes, packages, and markets pipe tobaccos. The NewGen Products segment trades e-cigarettes, e-liquids, vaporizers, and other related products; and distributes a wide assortment of vaping products to non-traditional retail outlets via VaporBeast and Vapor Shark. The company was founded by Martha C. Reider, Anne Cavanaugh and Richard C. Birkmeyer in 1990 and is headquartered in New York, NY. | Consumer Non-Durables |
Scriptgen Pharmaceuticals, Inc.
 Scriptgen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Scriptgen Pharmaceuticals, Inc. discovers and develops small molecule drugs. It develops antifungal and antibacterial drugs, as well as compounds for treatment of hepatitis. The company is headquartered in Medford, MA | Health Technology |
Orchid Cellmark, Inc.
 Orchid Cellmark, Inc. Miscellaneous Commercial ServicesCommercial Services Orchid Cellmark, Inc. provides DNA testing services. It generates genetic profile information by analysing an organism's unique genetic identity. The firm also offers non-DNA forensic laboratory services. The company was founded on March 8, 1995 and is headquartered in Princeton, NJ. | Commercial Services |
Aperio Technologies, Inc.
Aperio Technologies, Inc. Medical SpecialtiesHealth Technology Aperio Technologies, Inc. provided digital pathology systems and services. Its scanners created a digital image of an entire microscope slide at giga-pixel resolution in minutes, with inherently superior image quality. The company was founded in 1999 and was headquartered in Vista, CA. | Health Technology |
Gen-Probe, Inc.
 Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Health Technology |
Cylex, Inc.
Cylex, Inc. Medical SpecialtiesHealth Technology Cylex is a privately held global life science company that is in the development and manufacture of in vitrodiagnostic products. ImmuKnow is the in vitro diagnostic utilized to detect cell-mediated immunity (CMI) in an immunosuppressed population and is increasingly being adopted at organ transplant centers throughout the United States and abroad. The Company's patented technology provides a platform allowing clinical researchers to simply and reproducibly measure CMI for the development of new diagnostics, biomarkers and companion assays. The company is based in Columbia, MD and was founded in 1992 | Health Technology |
Quorex Pharmaceuticals, Inc.
 Quorex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quorex Pharmaceuticals, Inc. was previously engaged in discovering and developing drugs to address the growing need for new therapies to treat bacterial infections. The company's was purchased by Pfizer Inc in 2005. Quorex was headquartered in Carlsbad, CA. | Health Technology |
Galen Management LLC
Galen Management LLC Investment ManagersFinance Galen Management LLC (Galen Management) Is a private equity firm founded in 1990 by John Wilkerson and William Grant. The firm is headquartered in Stamford, Connecticut. | Finance |
| Healthcare Venture Associates | |
Alba Bioscience, Inc.
 Alba Bioscience, Inc. Medical SpecialtiesHealth Technology Quotient Biodiagnostics, Inc. engages in the manufacturing of immunohematology products. Its products include ABORh Reagents, Rare Antisera, Reagent Red Blood Cells, Anti Human Globulin Reagents, enhancement media and controls and specialty kits. The firm offers its products to blood banks and hospitals. Quotient Biodiagnostics was founded in 2009 and is headquartered in Newtown, PA. | Health Technology |
Quotient Ltd.
 Quotient Ltd. Electronic Equipment/InstrumentsElectronic Technology Quotient Ltd. is a commercial-stage diagnostics company, which provides immunohematology products to hospitals and blood banks. Its products and services include MOSAIQ and ALBA. The firm develops, manufactures, and sells conventional reagent products to equipment manufacturers. It engages in transfusion diagnostics, which focuses on blood grouping and serological disease screening. The company was founded on January 18, 2012 and is headquartered in Eysins, Switzerland. | Electronic Technology |
CDx Diagnostics, Inc.
CDx Diagnostics, Inc. Medical SpecialtiesHealth Technology CDx Diagnostics, Inc. develops and delivers instruments for detection and prevention of cancers. It is a specialized pathology lab that utilizes patented CDx Technology to analyze a disaggregated tissue specimen of the entire thickness of the suspect epithelium. The firm involves in detection and prevention of cancers of the esophagus, oral cavity, pharynx, and larynx. CDx Diagnostics provides clinicians with unique tools to enhance their detection of precancerous change through complete epithelial sampling combined with computer-assisted morphological and molecular laboratory analysis. The company was founded by Mark Rutenberg and Drore Eisen in 1997 and is headquarters in Suffern, NY. | Health Technology |
CDx Medical Holdings, Inc.
CDx Medical Holdings, Inc. Medical/Nursing ServicesHealth Services CDx Medical Holdings, Inc. engages in the provision of healthcare services. The company is headquartered in Suffern, NY. | Health Services |
